Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management

NCT00350649 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 205

Last updated 2011-09-27

No results posted yet for this study

Summary

Cognitive-behavioral coping skills therapy (CBT) is a widely used and recognized treatment that has been empirically validated for a range of substance use disorders, often with emergent effects and continuing improvement even after treatment ends. Treatment retention and compliance are associated with enhanced treatment outcomes in CBT. Contingency management (CM) also has very strong support and is associated with rapid, robust effects on targeted outcomes. Despite their many strengths, neither CBT nor CM is universally effective. It is now essential to seek strategies to maximize and extend the effectiveness of these two approaches and to better understand how these treatments exert their effects.

Conditions

  • Marijuana Dependence

Interventions

BEHAVIORAL

Standard CBT

Manualized delivery of CBT by trained clinicians

BEHAVIORAL

CBT+CM/adherence

CBT and Clinical Management for attendance and completing homework

BEHAVIORAL

CM/abstinence

Contingency Management

BEHAVIORAL

CM/abstinence+CBT

Contingency Management for abstinence in addition to manualized CBT delivered by a trained clinician

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Yale University

    lead OTHER

Principal Investigators

  • Kathleen Carroll, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350649 on ClinicalTrials.gov